Teva Pharmaceutical Industries News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

31.03.08	Teva Provides Update on Generic Prevacid(R) Litigation (Businesswire)
22.01.08	Teva Announces Extension to Standstill Agreement on Generic Protonix(R) (Businesswire)
14.01.08	Teva to Explore Strategic Alternatives for its Animal Health Business (Businesswire)
07.11.07	Initiation of Enrollment in Pivotal Phase III Clinical Study of Oral Laquinimod for Relapsing-Remitting Multiple Sclerosis (Businesswire)
30.10.07	Teva Announces Planned Retirement of CFO Dan Suesskind in Mid-2008 (Businesswire)
30.10.07	Teva Reports Third Quarter 2007 Results (Businesswire)
12.10.07	Long-Term Study Shows COPAXONE(R) Significantly Slows Progression of Disability and Reduces Relapse Rates in Patients with Relapsing-Remitting Multiple Sclerosis (Businesswire)
29.06.07	Teva Announces Approval of Amlodipine Besylate Tablets (Businesswire)
06.06.07	COPAXONE(R) Pre-Filled Syringe Can Now Be Stored for up to One Month at Room Temperature (Businesswire)
27.02.07	Post-Hoc Data Analyses Published in Annals of Neurology Found COPAXONE(R) Significantly Delayed Accumulated Disability in Male Patients with Primary Progressive Multiple Sclerosis (PPMS) (Businesswire)
03.01.06	IVAX and Teva Decline ``Public Acquirer Fundamental Change'' Option for IVAX' 1.5% Convertible Senior Notes Due 2025 (Businesswire)
25.11.05	Teva and IVAX Receive European Commission Approval for Acquisition (Businesswire)
16.05.05	Teva's Fenofibrate Product Receives Final Approval; Seeks Three Times (Businesswire)
03.05.05	Teva to Broadcast First Quarter 2005 Earnings Luncheon on the Web (Businesswire)
03.05.05	Teva Reports First Quarter 2005 Results; Copaxone Becomes US Prescript (Businesswire)
27.04.05	CORRECTING and REPLACING Teva Announces Approval of Clozapine Tablets, (Businesswire)
14.04.05	Novel Approach with COPAXONE Showed Dramatic Improvements in Aggressiv (Businesswire)
30.03.05	Teva Announces Tentative Approval of Octreotide Acetate Injection (Businesswire)
22.03.05	Teva and Active Biotech Announce That Laquinimod Phase II Data Has Bee (Businesswire)
16.02.05	Teva and Gamida-Cell Will Develop and Commercialize StemEx for the Tre (Businesswire)
15.02.05	Teva Reports Record Sales and Net Income for Q4 2004; Record Annual Sa (Businesswire)
13.02.05	Teva Announces Tentative Approval of Levofloxacin Injection (Businesswire)
11.02.05	Teva and Savient Launch TEV-TROPIN for Pediatric Growth Hormone Defici (Businesswire)
10.02.05	Teva Announces Approval of Amoxicillin and Clavulanate Potassium Chewa (Businesswire)
02.02.05	Teva to Report 2004 Financial Results on February 15, 2005; Conference (Businesswire)
28.01.05	Teva Announces Approval of Glyburide/Metformin HCl Tablets (Businesswire)
27.01.05	Teva Announces Final Approval of Levofloxacin Tablets, 750 mg (Businesswire)
26.01.05	Teva Announces Global in-Market Fourth Quarter Sales of Copaxone Incre (Businesswire)
14.01.05	Teva Announces Approval of Fluconazole Injection (Businesswire)
03.01.05	Teva Announces That Azilect -Rasagiline- is Approved for Marketing in (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	537.00	1.13 %	K V
Part Grp Hldg	1’259.00	0.64 %	K V
Roche Hldg G	252.60	0.48 %	K V
Novartis	92.26	0.36 %	K V
Alcon	77.88	0.33 %	K V
Swiss Life Hldg	716.20	-0.44 %	K V
ABB	49.26	-0.57 %	K V
UBS Group	27.59	-0.61 %	K V
Sika	226.30	-1.01 %	K V
Logitech Intl	70.50	-2.06 %	K V

mehr

13:37		Novartis-Aktie etwas höher: EU-Zulassung für Kisqali - Funktion des Schweizer Länderpräsidenten gestrichen
12:26		Gewinne in London: FTSE 100 am Mittag mit Kursplus
12:26		Börse Zürich in Rot: SLI gibt nach
12:26		Börse Zürich in Rot: So bewegt sich der SMI am Mittag
09:28		FTSE 100 aktuell: FTSE 100 steigt zum Start des Mittwochshandels
26.11.24		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
26.11.24		Börse Zürich: SMI letztendlich in Rot
26.11.24		FTSE 100 aktuell: FTSE 100 fällt zum Handelsende